Neurology
15 Apr 2025
Phase II Trial Shows Clinical and Imaging Evidence of Brain Repair in MS: AAN 2025
At the American Academy of Neurology (AAN) Annual Meeting 2025, researchers presented new data from the long-term open-label extension of the Phase II VISIONARY-MS trial, reporting imaging and physiologic findings consistent with improved neuronal function and remyelination in patients with multiple sclerosis (MS).
